Abstract
DT are rare, locally aggressive soft-tissue tumors without approved systemic therapy. Nirogacestat (niro), a novel oral gamma secretase inhibitor (GSI) has shown antitumor activity in patients with DT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have